本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vaxcyte, Inc.

34.68
-1.1900-3.32%
盘后34.860.1800+0.52%17:45 EDT
成交量:108.69万
成交额:3,792.53万
市值:44.74亿
市盈率:-8.71
高:35.93
开:35.93
低:34.66
收:35.87
数据加载中...
2021/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

重要事件披露

8-K - Current report
2020/12/22

重要事件披露

8-K - Current report
2020/11/12

重要事件披露

8-K - Current report
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/16

重要事件披露

8-K - Current report
2020/06/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans